Regulatory & Legal

After navigating pandemics and geopolitical crises as IOC head, Thomas Bach now brings his leadership playbook to the world's top boardrooms via Keppler Speakers.

Copan's PhenoMATRIX® gains FDA 510(k) clearance, unleashing AI to speed up bacterial analysis and reshape the future of clinical diagnostics in America.

With 125M devices deployed and major regulatory wins for satellite IoT, the LoRaWAN standard is cementing its role as essential global infrastructure.

With $100M from major investors, Utility Global is set to deploy its H2Gen® tech, which creates clean hydrogen from industrial waste gas, not electricity.

New research reveals near-universal AI use among marketers, but finds consumers prioritize content quality over disclosure, elevating the need for human oversight.

A new powerhouse is born in the watch world as AEG buys E. Gluck, merging a story of Holocaust survival and legacy with modern scale and global ambition.

The largest study of its kind reveals metabolic signatures that predict severe neurotoxicity in CAR T-cell patients, paving the way for safer treatments.

A new book introduces a controversial but promising treatment that reframes trauma as a physical injury, offering a biological 'reset' for the nervous system.

Digital asset firm ReserveOne moves closer to a public debut via a SPAC deal, testing the waters for crypto companies in a shifting regulatory climate.

A new project in Galva, Illinois, aims to store 725,000 tons of CO2 yearly, tapping into massive federal tax credits to redefine the future of biofuels.

Vast's first NASA-backed mission to the ISS is a key step in the race to build private space stations before the iconic outpost retires in 2031.

With new Series A funding, Daffodil Health's AI platform aims to dismantle the opaque, costly systems that drive up U.S. healthcare spending.

A foodservice supplier's foundation marks one year by planting 373,000 trees and saving vital species, pioneering a new model for corporate responsibility.

Sanofi promotes Dupixent growth driver Manuela Buxo to lead its crucial Specialty Care unit, ensuring continuity as competition and a new AI focus intensify.

With a new CTO and fortified legal and quality chiefs, Integra LifeSciences is making a bold play to accelerate innovation and shore up compliance.

A top shareholder claims Japan's leading toilet maker is a key AI supplier, revealing a $3.6B value gap and demanding a radical corporate transformation.

A major update to the Kosmos platform brings cart-grade OB/GYN and vascular tools to a portable device, reshaping diagnostics from the ER to rural clinics.

A new report shows most audit leaders see AI fraud as a top risk, yet less than 40% feel equipped to fight it, exposing a critical corporate vulnerability.

In a landmark $9.9 billion all-cash deal, Danaher will acquire Masimo, aiming to dominate the patient monitoring market from hospital to home.

Acorns adds free tax filing, but the real play is its push to automatically invest your refund, a move aimed at reshaping personal finance habits.